Timber Pharmaceuticals Stock Fundamentals
Timber Pharmaceuticals fundamentals help investors to digest information that contributes to Timber Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Timber Stock. The fundamental analysis module provides a way to measure Timber Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Timber Pharmaceuticals stock.
Timber |
Timber Pharmaceuticals Company Return On Equity Analysis
Timber Pharmaceuticals' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Timber Pharmaceuticals Return On Equity | -3.43 |
Most of Timber Pharmaceuticals' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Timber Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Timber Pharmaceuticals has a Return On Equity of -3.4324. This is 85.68% lower than that of the Biotechnology sector and 90.59% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
Timber Pharmaceuticals Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Timber Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Timber Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Timber Pharmaceuticals competition to find correlations between indicators driving Timber Pharmaceuticals's intrinsic value. More Info.Timber Pharmaceuticals is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Timber Pharmaceuticals by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Timber Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Timber Pharmaceuticals' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Timber Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Timber Pharmaceuticals by comparing valuation metrics of similar companies.Timber Pharmaceuticals is currently under evaluation in return on equity category among its peers.
Timber Fundamentals
Return On Equity | -3.43 | |||
Return On Asset | -1.37 | |||
Current Valuation | (916.94 K) | |||
Shares Outstanding | 3.43 M | |||
Shares Owned By Insiders | 1.11 % | |||
Shares Owned By Institutions | 7.78 % | |||
Number Of Shares Shorted | 7.91 K | |||
Price To Book | 6.94 X | |||
Price To Sales | 17.19 X | |||
Revenue | 83.18 K | |||
Gross Profit | (5.26 M) | |||
EBITDA | (19.16 M) | |||
Net Income | (19.38 M) | |||
Cash And Equivalents | 11.22 M | |||
Cash Per Share | 3.78 X | |||
Total Debt | 331.15 K | |||
Debt To Equity | 0.06 % | |||
Current Ratio | 2.45 X | |||
Book Value Per Share | (0.86) X | |||
Cash Flow From Operations | (15.85 M) | |||
Short Ratio | 0.21 X | |||
Earnings Per Share | (1.97) X | |||
Target Price | 11.0 | |||
Beta | -0.65 | |||
Market Capitalization | 1.18 M | |||
Total Asset | 10.28 M | |||
Retained Earnings | (48.26 M) | |||
Working Capital | 4.77 M | |||
Z Score | -10.03 | |||
Net Asset | 10.28 M |
Pair Trading with Timber Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Timber Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Timber Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to First Solar could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace First Solar when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back First Solar - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling First Solar to buy it.
The correlation of First Solar is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as First Solar moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if First Solar moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for First Solar can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Consideration for investing in Timber Stock
If you are still planning to invest in Timber Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Timber Pharmaceuticals' history and understand the potential risks before investing.
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |